Tonic Versus Burst DR(TM) Epidural Motor Cortex Stimulation for Neuropathic Pain

Last updated: August 22, 2024
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Overall Status: Completed

Phase

N/A

Condition

Oral Facial Pain

Chronic Pain

Pain (Pediatric)

Treatment

Retrospective analysis of patients' choice

Clinical Study ID

NCT05984329
IRBN872022/CHUSTE
  • Ages > 18
  • All Genders

Study Summary

Epidural stimulation of the primary motor cortex (PMC) is indicated for the relief of neuropathic pain refractory to pharmacological treatment.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients suffering from neuropathic pain refractory to best pharmacologicaltreatment, operated on for MCS with an internal pulse generator (IPG) capable ofdelivering both tonic and Burst DR(TM) stimulation waveforms.

Exclusion

Exclusion Criteria:

  • Patients under 18 years old ; pregnancy

Study Design

Total Participants: 14
Treatment Group(s): 1
Primary Treatment: Retrospective analysis of patients' choice
Phase:
Study Start date:
July 15, 2022
Estimated Completion Date:
May 15, 2024

Study Description

The main objective of this study is to compare the analgesic effect of two distinct waveforms (i.e. tonic versus Burst DR(TM)) delivered by an epidural stimulator of the (primary) motor cortex in patients suffering from neuropathic pain resistant to the best pharmacological treatment.

Connect with a study center

  • Chu Saint-Etienne

    Saint-Étienne, 42000
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.